Ikeda, Y., Oda, K., Ishihara, H., Wada-Hiraike, O., Miyasaka, A., Kashiyama, T., . . . Fujii, T. (2015). Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy. Br J Cancer.

Ikeda, Yuji, et al. "Prognostic Importance of CDK4/6-specific Activity As a Predictive Marker for Recurrence in Patients With Endometrial Cancer, With or Without Adjuvant Chemotherapy." Br J Cancer 2015.

Ikeda, Yuji, et al. "Prognostic Importance of CDK4/6-specific Activity As a Predictive Marker for Recurrence in Patients With Endometrial Cancer, With or Without Adjuvant Chemotherapy." Br J Cancer 2015.